UBS upgraded AddLife (ADDLF) to Buy from Neutral with a SEK 165 price target The company’s outlook is improving and the stock’s valuation is “undemanding,” the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADDLF:
- AddLife Maintains High Margins and Speeds Up Deal-Making as 2026 Begins
- Is ADDLF a Buy, Before Earnings?
- AddLife strengthens coagulation diagnostics portfolio with CoaChrom acquisition
- AddLife Publishes Comprehensive 2025 Annual Report Covering Strategy, Governance and Sustainability
- AddLife Calls 2026 AGM With Incentive Plan and Share Issue Mandates on Agenda